malondialdehyde has been researched along with Amyloidosis in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
An, L; Cai, JH; Wang, CY; Wang, T; Wang, X; Wang, ZY; Xie, JW; Xu, Y; Zhao, BL | 1 |
Bilge, M; Capraz, I; Celik, G; Mehmetoglu, I; Unaldi, M; Yontem, M | 1 |
2 other study(ies) available for malondialdehyde and Amyloidosis
Article | Year |
---|---|
Trientine reduces BACE1 activity and mitigates amyloidosis via the AGE/RAGE/NF-κB pathway in a transgenic mouse model of Alzheimer's disease.
Topics: Alzheimer Disease; Amyloid Precursor Protein Secretases; Amyloidosis; Animals; Aspartic Acid Endopeptidases; Cell Line, Tumor; Cerebral Cortex; Ceruloplasmin; Chelating Agents; Copper; Down-Regulation; Female; Glycation End Products, Advanced; Humans; Malondialdehyde; Mice; Mice, Inbred C57BL; Mice, Transgenic; NF-kappa B; Receptor for Advanced Glycation End Products; Receptors, Immunologic; Signal Transduction; Superoxide Dismutase; Superoxide Dismutase-1; Trientine | 2013 |
The relationship between the antioxidant system, oxidative stress and dialysis-related amyloidosis in hemodialysis patients.
Topics: Aged; Amyloidosis; Antioxidants; beta 2-Microglobulin; Female; Humans; Male; Malondialdehyde; Middle Aged; Oxidative Stress; Renal Dialysis; Superoxide Dismutase; Tendons | 2013 |